Skip to main content
ECCO News 2023/3

Volume 18, Issue 3

Featured Articles


The Educational Programme of the 19th Congress of ECCO starts prior to the official start of the ECCO Congress and courses take place from February 21-24, 2024. These activities target ECCO’s different interest groups including young gastroenterologists, surgeons, paediatricians, pathologists, IBD Nurses, dietitians, allied health professionals and scientists.
Marc Ferrante, ECCO MemberPauline Rivière, ECCO MemberYves Panis, ECCO Member
Marc Ferrante, SciCom Chair, Yves Panis, SciCom Member and Pauline Rivière, ECCO Member
For two years, a group of 25 IBD specialists, including gastroenterologists, surgeons and scientists, have been working to build a research framework for postoperative recurrence (POR) in patients with Crohn’s Disease. Even though more biological therapies are now available, ileocaecal resection is still a frequent event and POR management remains a challenge for both patients and IBD specialists.
Shai Bel, ECCO Member
Shai Bel, ECCO Grant Awardee
The role of autophagy in limiting IBD-associated AIEC-induced intestinal inflammation While the aetiology underlying the development of Inflammatory Bowel Diseases (IBD) is unclear, evidence points to an interaction between host genetics, such as mutations in autophagy genes, and environmental factors, such as bacterial infections.
Sudipto Das, ECCO Grant Awardee
Sudipto Das, ECCO Grant Awardee
Role of DNA methYlation and geNe expression alterations in development of eArly-onset priMary sclerosIng cholangitis in ulCerative colitis – DYNAMIC Primary Sclerosing Cholangitis (PSC) is a progressive choleostatic disease and up to 80% of patients also have Ulcerative Colitis (PSC-UC). This presents a clinical challenge owing to the diagnostic difficulty and the increased risk for development of cancer.
Ho-Su Lee, ECCO Grant Awardee
Ho-Su Lee, ECCO Grant Awardee
Investigating the genetics of IBD multiplex families This research aimed to investigate the genetic architecture of Inflammatory Bowel Disease (IBD) multiplex families (including at least three affected first-degree relatives), and to identify the underlying genetic factors that contribute to the familial aggregation of IBD.